Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Reduction in BP Drives Treatment Preference for Hypertensive Patients

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

December 02, 2022

TCTMD’s Top 10 Most Popular Stories for November 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

December 01, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

November 07, 2022

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

News Daily News

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

November 01, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Stroke Thrombectomy May Work for Large Infarcts in the Late Time Window

News Daily News

Stroke Thrombectomy May Work for Large Infarcts in the Late Time Window

October 20, 2022

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

October 19, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

September 17, 2022

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

RESCUE BT: IV Tirofiban No Help During Stroke Thrombectomy

News Daily News

RESCUE BT: IV Tirofiban No Help During Stroke Thrombectomy

August 09, 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

May 23, 2022

Percutaneous Axillary Access: SCAI Calls for Best Practices

News Daily News

Percutaneous Axillary Access: SCAI Calls for Best Practices

April 20, 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

April 04, 2022

Stroke Thrombectomy Also Benefits Kids, Observational Study Shows

News Conference News ISC 2022

Stroke Thrombectomy Also Benefits Kids, Observational Study Shows

February 16, 2022

Robert M. Califf Becomes 25th Commissioner of the US FDA

News Daily News

Robert M. Califf Becomes 25th Commissioner of the US FDA

February 15, 2022

Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT

News Conference News ISC 2022

Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT

February 09, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.